CLIPS BnC Inc.
![CLIPS BnC Inc.](https://www.medidata.com/wp-content/themes/md/v2/static/images/home-background.webp)
![Company Name of Partner](https://www.medidata.com/wp-content/uploads/2023/06/clips-1024x353.png)
CLIPS BnC Inc. (the Company) is a full scope clinical contract research organization (CRO), and a biotechnology company focusing on the development of novel cell therapeutics and vaccines. As a CRO, the company provides comprehensive clinical development services, such as regulatory affairs consulting, medical writing, clinical trial management, and data management & statistics, to biopharmaceutical companies. The company is actively expanding its business overseas by establishing CLIPS BnC Thailand and a joint venture in China to address the needs of strategic partners in the APAC region. As a biotech, the company is developing a limbal stem cell therapy, which is about to enter the Phase 2 trial, and vaccines for infectious diseases with unmet medical needs, including respiratory syncytial virus (RSV) and methicillin resistant Staphylococcus aureus (MRSA).
Locations
- APAC